Agile Therapeutics (AGRX)
(Delayed Data from OTC)
$1.43 USD
-0.01 (-0.69%)
Updated Jul 9, 2024 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMIndustry / Sector Report
Industry : Medical - Generic Drugs
Zacks Industry Rank
Top 34% (63 out of 250)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.42 | 9.99 |
Current Quarter Estimate | NA | 1.25 | 61.00 |
Year Ago Quarter Estimate | NA | -4.28 | 54.84 |
Next Quarter Estimate | NA | 1.37 | 63.00 |
Next Year Estimate | NA | 7.08 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | NA | NA | NA |
Next Year | NA | NA | NA |
Last 5 Years | NA | NA | NA |
Next 5 Years | NA | NA | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 1.64 |
Price/Book (MRQ) | NA | 1.31 |
Price/Cash Flow (MRFY) | NA | 10.20 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -36.24% | NA |
Return on Equity (TTM) | NA | NA |
Debt to Equity (MRQ) | NA | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.